Gayle Crowell's Insider Trades & SAST Disclosures
Gayle Crowell's most recent trade in Hercules Capital Inc was a trade of 5,790 Common Stock done at an average price of $18.1 . Disclosure was reported to the exchange on Aug. 6, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Gayle Crowell.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Hercules Capital Inc | Gayle Crowell | Director | Purchase of securities on an exchange or from another person at price $ 18.06 per share. | 06 Aug 2024 | 5,790 | 59,366 (0%) | 0% | 18.1 | 104,592 | Common Stock |
| Hercules Capital Inc | Gayle Crowell | Director | Purchase of securities on an exchange or from another person at price $ 20.07 per share. | 25 Jun 2024 | 701 | 53,576 (0%) | 0% | 20.1 | 14,067 | Common Stock |
| Hercules Capital Inc | Gayle Crowell | Director | Grant, award, or other acquisition of securities at price $ 19.80 per share. | 20 Jun 2024 | 3,030 | 52,874 (0%) | 0% | 19.8 | 59,994 | Common Stock |
| Pliant Therapeutics Inc | Gayle Crowell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 26,764 | 26,764 | - | - | Common Stock (Right to Buy) | |
| Envestnet Inc. | Gayle Crowell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Feb 2024 | 3,987 | 17,075 (0%) | 0% | 0 | Common Stock | |
| Hercules Capital Inc | Gayle Crowell | Director | Grant, award, or other acquisition of securities at price $ 15.72 per share. | 22 Nov 2023 | 1,051 | 47,740 (0%) | 0% | 15.7 | 16,522 | Common Stock |
| Hercules Capital Inc | Gayle Crowell | Director | Grant, award, or other acquisition of securities at price $ 15.87 per share. | 22 Nov 2023 | 149 | 46,689 (0%) | 0% | 15.9 | 2,365 | Common Stock |
| Hercules Capital Inc | Gayle Crowell | Director | Grant, award, or other acquisition of securities at price $ 15.90 per share. | 08 Sep 2023 | 5,656 | 46,540 (0%) | 0% | 15.9 | 89,930 | Common Stock |
| Hercules Capital Inc | Gayle Crowell | Director | Grant, award, or other acquisition of securities at price $ 16.44 per share. | 25 Aug 2023 | 812 | 40,884 (0%) | 0% | 16.4 | 13,349 | Common Stock |
| Hercules Capital Inc | Gayle Crowell | Director | Grant, award, or other acquisition of securities at price $ 16.41 per share. | 25 Aug 2023 | 144 | 40,072 (0%) | 0% | 16.4 | 2,363 | Common Stock |
| Pliant Therapeutics Inc | Gayle Crowell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2023 | 14,000 | 14,000 | - | - | Stock Option (Right to Buy) | |
| Hercules Capital Inc | Gayle Crowell | Director | Grant, award, or other acquisition of securities at price $ 13.87 per share. | 23 May 2023 | 865 | 39,928 (0%) | 0% | 13.9 | 11,998 | Common Stock |
| Hercules Capital Inc | Gayle Crowell | Director | Grant, award, or other acquisition of securities at price $ 13.09 per share. | 23 May 2023 | 218 | 39,063 (0%) | 0% | 13.1 | 2,854 | Common Stock |
| Hercules Capital Inc | Gayle Crowell | Director | Purchase of securities on an exchange or from another person at price $ 13.66 per share. | 08 May 2023 | 7,200 | 38,845 (0%) | 0% | 13.7 | 98,352 | Common Stock |
| Hercules Capital Inc | Gayle Crowell | Director | Grant, award, or other acquisition of securities at price $ 15.33 per share. | 09 Mar 2023 | 755 | 31,645 (0%) | 0% | 15.3 | 11,574 | Common Stock |
| Hercules Capital Inc | Gayle Crowell | Director | Grant, award, or other acquisition of securities at price $ 15.32 per share. | 09 Mar 2023 | 187 | 30,890 (0%) | 0% | 15.3 | 2,865 | Common Stock |
| Envestnet Inc. | Gayle Crowell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2023 | 3,208 | 13,088 (0%) | 0% | 0 | Common Stock | |
| Hercules Capital Inc | Gayle Crowell | Director | Grant, award, or other acquisition of securities at price $ 14.32 per share. | 17 Nov 2022 | 839 | 30,703 (0%) | 0% | 14.3 | 12,014 | Common Stock |
| Hercules Capital Inc | Gayle Crowell | Director | Grant, award, or other acquisition of securities at price $ 14.06 per share. | 17 Nov 2022 | 220 | 29,863 (0%) | 0% | 14.1 | 3,093 | Common Stock |
| Hercules Capital Inc | Gayle Crowell | Director | Grant, award, or other acquisition of securities at price $ 15.76 per share. | 16 Aug 2022 | 718 | 29,643 (0%) | 0% | 15.8 | 11,316 | Common Stock |
| Hercules Capital Inc | Gayle Crowell | Director | Grant, award, or other acquisition of securities at price $ 15.13 per share. | 16 Aug 2022 | 201 | 28,925 (0%) | 0% | 15.1 | 3,041 | Common Stock |
| Hercules Capital Inc | Gayle Crowell | Director | Grant, award, or other acquisition of securities at price $ 16.13 per share. | 01 Aug 2022 | 4,339 | 28,724 (0%) | 0% | 16.1 | 69,996 | Common Stock |
| Pliant Therapeutics Inc | Gayle Crowell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 15,000 | 15,000 | - | - | Stock Option (right to buy) | |
| Hercules Capital Inc | Gayle Crowell | Director | Grant, award, or other acquisition of securities at price $ 13.82 per share. | 24 May 2022 | 799 | 24,385 (0%) | 0% | 13.8 | 11,042 | Common Stock |
| Hercules Capital Inc | Gayle Crowell | Director | Grant, award, or other acquisition of securities at price $ 17.17 per share. | 16 Mar 2022 | 643 | 23,586 (0%) | 0% | 17.2 | 11,040 | Common Stock |
| Envestnet Inc. | Gayle Crowell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2022 | 2,352 | 9,880 (0%) | 0% | 0 | Common Stock | |
| Hercules Capital Inc | Gayle Crowell | Director | Grant, award, or other acquisition of securities at price $ 17.33 per share. | 17 Nov 2021 | 521 | 22,942 (0%) | 0% | 17.3 | 9,029 | Common Stock |
| Hercules Capital Inc | Gayle Crowell | Director | Grant, award, or other acquisition of securities at price $ 16.98 per share. | 18 Aug 2021 | 498 | 22,421 (0%) | 0% | 17.0 | 8,456 | Common Stock |
| Hercules Capital Inc | Gayle Crowell | Director | Grant, award, or other acquisition of securities at price $ 17.44 per share. | 02 Aug 2021 | 4,013 | 21,923 (0%) | 0% | 17.4 | 69,987 | Common Stock |
| Pliant Therapeutics Inc | Gayle Crowell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jun 2021 | 13,286 | 13,286 | - | - | Stock Option (right to buy) | |
| Hercules Capital Inc | Gayle Crowell | Director | Grant, award, or other acquisition of securities at price $ 17.28 per share. | 24 Jun 2021 | 3,472 | 17,910 (0%) | 0% | 17.3 | 59,996 | Common Stock |
| Hercules Capital Inc | Gayle Crowell | Director | Grant, award, or other acquisition of securities at price $ 15.98 per share. | 19 May 2021 | 329 | 14,438 (0%) | 0% | 16.0 | 5,257 | Common Stock |
| Hercules Capital Inc | Gayle Crowell | Director | Purchase of securities on an exchange or from another person at price $ 17.50 per share. | 03 May 2021 | 377 | 14,109 (0%) | 0% | 17.5 | 6,598 | Common Stock |
| Hercules Capital Inc | Gayle Crowell | Director | Grant, award, or other acquisition of securities at price $ 16.60 per share. | 15 Mar 2021 | 124 | 13,732 (0%) | 0% | 16.6 | 2,058 | Common Stock |
| Envestnet Inc. | Gayle Crowell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2021 | 2,605 | 7,528 (0%) | 0% | 0 | Common Stock | |
| Hercules Capital Inc | Gayle Crowell | Director | Grant, award, or other acquisition of securities at price $ 11.49 per share. | 16 Nov 2020 | 154 | 13,608 (0%) | 0% | 11.5 | 1,769 | Common Stock |
| Hercules Capital Inc | Gayle Crowell | Director | Grant, award, or other acquisition of securities at price $ 11.40 per share. | 06 Nov 2020 | 4,379 | 13,454 (0%) | 0% | 11.4 | 49,921 | Common Stock |
| Hercules Capital Inc | Gayle Crowell | Director | Grant, award, or other acquisition of securities at price $ 11.93 per share. | 17 Aug 2020 | 178 | 9,074 (0%) | 0% | 11.9 | 2,124 | Common Stock |
| Hercules Capital Inc | Gayle Crowell | Director | Grant, award, or other acquisition of securities at price $ 10.33 per share. | 21 May 2020 | 205 | 8,896 (0%) | 0% | 10.3 | 2,118 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges